Skip to main content

Advertisement

Table 3 Analysis of melanoma recurrence according to MMP-23 expression in the entire cohort and the subset of patients who received immunotherapy after primary resection

From: Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy

  MMP-23 composite score
Entire cohorta Immunotherapy after primary resectionb
0 - 2 3 - 4 0 - 2 3 - 4
Recurrence     
Yes 11 (59%) 42 (81%) 5 (46%) 23 (79%)
No 8 (41%) 10 (19%) 6 (54%) 6 (21%)
Total 19 (100%) 52 (100%) 11 (100%) 29 (100%)
  1. aP = 0.067; bP = 0.056.